Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AB, Abstract, ActionNo, admission, AHA, Allergan, Apotex, asymptomatic, BESP, biopharm, BNP, burden, Capricor, cardiopulmonary, CaseNo, CIS, clarify, CMC, coincident, College, Commonwealth, composite, Condensed, confidence, Degeneration, edaravone, Edison, edward, elevated, eroded, EU, field, Fire, Frontotemporal, FVC, GAAP, Genentech, Glenmark, guiding, ibudilast, includingpre, incremental, inRule, Intercompany, Italfarmaco, kaye, Lancet, logo, LVEF, Mallinckrodt, Marindale, masitinib, mecarbilconducted, mecobalamin, mildly, moderate, moderately, modest, modification, noncash, NYHA, ofASC, onForm, Origent, plaintiff, prejudice, premium, proper, questionnaire, Radicut, reallocation, reconsider, recoup, refine, remediated, remediation, repeal, repealed, resolution, resting, Riluteck, Rilutek, RPI, Russia, safest, Science, score, screening, session, SPA, Spinraza, spirometry, standalone, summarized, Summit, Sun, supervision, symptomatic, thisForm, Trump, Trust, TSS, UK, unblinded, uncured, unexpected, VM, vTv, waive, writing, wrongdoing
Removed:
Acorda, activin, affording, aladorian, alter, androgen, antagonist, artery, autoimmune, bimagrumab, biomarker, breath, bucindolol, Carpicor, Celladon, cenderitide, Codification, cramping, denervating, Directive, disability, disorder, dissolution, Education, enzyme, eventually, exited, expended, feature, geographic, glial, historically, initiating, involuntarily, junior, lawful, leg, liquidation, modulator, move, Mydicar, Neurocardin, nominated, ostarine, Overview, pain, parity, peptide, peripheral, playing, pro, Procoralan, prohibited, ranked, Reasanz, reclassified, remained, retained, serelaxin, ularitide, unchanged, voluntarily, voting, winding
Filing tables
Filing exhibits
Related press release
CYTK similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on FormS-3 (Nos.333-206795 and333-215147) andForm S-8 (Nos.333-115146,333-125973,333-133323,333-136524,333-140963,333-149713,333-152850,333-161116,333-168520,333-176089,333-183091,333-190458 and333-206101) of Cytokinetics, Incorporated of our report dated March 6, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in thisForm 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 6, 2017